Before taking Truqap(Capivasertib)

Critical safety warnings and precautions for users.

Warnings and Precautions

Key safety concerns include the risk of hyperglycemia, which requires blood glucose monitoring before and during treatment; severe diarrhea necessitating prompt management; and serious cutaneous adverse reactions. TRUQAP can cause fetal harm based on its mechanism of action, necessitating effective contraception in patients of reproductive potential. Concomitant use with strong CYP3A inhibitors should be avoided, and dose reductions are required with moderate CYP3A inhibitors.